Maryland, Virginia, Washington, D.C., and Philadelphia
Good morning, all! We kick off this week highlighting how gene therapy is helping scientists and biotechs such as American Gene Technologies spearhead potential HIV cures.
We also share insights on how incoming PhD students can start prepping for a non-academic job, even in their first year. And speaking of scientists moving beyond the bench, don't miss our interview with Workforce Genetics recruiter Paul Streng, who discusses how his years in the lab helped him understand exactly what his life science recruiting clients are looking for.
The Director, Education and Workforce Development, is accountable for the development, implementation, and active management of training strategies, plans and processes to support the workforce development goals and objectives of ARMI | BioFabUSA. You are responsible for all training programs involving K-grey... Read More
In this exciting new area of cancer immunotherapy, you will assist in the commissioning and operation of a GMP warehouse and inventory management system. In this role, you will perform activities to support the manufacturing operations team, including product shipping, raw material and component receiving.... Read More
Workforce Genetics (on Behalf of Client) | Rockville, MD
Our client seeking a highly motivated Scientist - Biomarker Assays | Flow Cytometry with great inter-personal & leadership skills who could complement our dynamic and growing company! The scientist’s role is to work as part of a team to carry out analytical work within the assigned projects to execute activities... Read More
Code Biotherapeutics, Inc. (Code Bio) announced its upsized and oversubscribed Series A financing of $75 million to advance programs to treat and cure rare and prevalent... Read More
One year after Rami Elghandour joined Arcellx, Inc., a cell therapy company based in Gaithersburg, MD, and Foster City, CA, as the company’s new chairman and CEO, he took the... Read More
One of the reasons that cancer is notoriously difficult to treat is that it can look very different for each patient. As a result, most targeted therapies only work for a fraction of cancer patients... Read More
Antibiotics are 42% more likely to be in shortage compared to all other drugs, according to the latest analysis from the U.S. Pharmacopeia’s (USP) Medicine Supply Vulnerability... Read More
Please join ICAP and Virginia Bio, along with our Charlottesville Co-Host CvilleBioHub and Norfolk Co-Host 757 Accelerate, as our Life Science Mentor Philippe Sommer discusses... Read More
The Bisnow Life Sciences Summit will be a prime chance to see up close the newest turn-key opportunities for science at the Budd Campus. Budd Bioworks is the new strategic home... Read More
